Dr. Guy Heathers is a Co-Founder and Chief Business Officer of Albatroz Therapeutics. Guy has over 30 years of international experience in growing and developing technologies for biopharma start-ups. In addition to his current role at Albatroz, he is also an IP consultant to a number of Singapore biotech companies including Twain Therapeutics, Tessa Therapeutics, Carmine Therapeutics and Hoow Foods. Guy also served as IP Advisor for Enleofen, a Singapore start-up for fibrotic diseases that he helped to create at SingHealth/Duke-NUS which secured a significant buyout deal with Boehringer Ingelheim. He also held CEO, VP, COO or CBO positions at Hummingbird Bioscience Pte Ltd, Cancer Therapeutics Pty Ltd, Amaranth Medical Pte Ltd, Gateway Capital Pty Ltd, Biotech Research Ventures Ltd, and Cancer Research Ventures Ltd in the UK, Singapore and Australia.